| Biotechnology Industry | Healthcare Sector | Dr. Wei Rao CEO | XSHE Exchange | CNE100003T39 ISIN |
| CN Country | 2,841 Employees | 27 May 2026 Last Dividend | 21 May 2021 Last Split | - IPO Date |
Shenzhen New Industries Biomedical Engineering Co., Ltd. (NIBEC) is a pioneering force in the bio-medical field. Established in 1995, the company has cemented its reputation for innovation and quality in the healthcare sector. NIBEC specializes in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents. Catering to the needs of hospitals both within the People's Republic of China and on an international scale, NIBEC combines technological advancement with practical application, addressing the evolving demands of diagnostics and patient care. Headquartered in Shenzhen, one of China's leading technology hubs, NIBEC is at the forefront of the bio-medical industry, pushing the boundaries of what is possible in medical diagnostics and laboratory operations.
NIBEC offers a comprehensive range of products and services designed to enhance the efficiency and effectiveness of medical diagnostics and research. The company’s portfolio includes: